Patricia Tung, MD
Clinical Cardiac Electrophysiology · Boston, MANPI 1104978857
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 27.1% of the total. 2025 is the largest year on record at $49,845, 8.7 times the $5,747 reported in 2019.
Across 193 payments — averaging $508.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$27K
- Abbott$21K
- Medtronic$21K
- Biosense Webster, Inc.$16K
- Medical Device Business Services, Inc.$7K
- ZOLL Respicardia, Inc.$3K
- plus $4K from 4 others
Across 46 payments — averaging $8448.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$351K
- Boston Scientific$37K
What the payments were for
- Consulting fees$40,45741%
- Speaking & faculty fees$39,62540%
- Travel & lodging$11,41812%
- Food & beverage$6,5847%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $26,549 |
| Abbott | 75 | $20,806 |
| Medtronic(2 entities) | 37 | $20,639 |
| Biosense Webster, Inc. | 27 | $16,390 |
| Medical Device Business Services, Inc. | 5 | $6,880 |
| ZOLL Respicardia, Inc. | 3 | $2,837 |
| Sanofi-aventis U.S. LLC | 1 | $2,088 |
| Biotronik Inc. | 17 | $1,732 |
| Elutia, Inc. | 1 | $137 |
| Cordis US CORP. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$22,435
- Farapulse$16,496
- GALLANT$13,030
- VersaCross Large Access Solution$9,375
- ENSITE$4,307
- remede System$2,755
- MULTAQ$2,088
- ENSITE PRECISION$991
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$525
- VersaCross RF Wire$174
- Micra$168
- ACCOLADE SR$138
- ECM Patch,Pouch$137
- Acticor 7 VR-T DX$135
- QUADRA ASSURA$118
How this compares
$98,083 in reported general payments places this provider in the 80th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.
See all clinical cardiac electrophysiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 50 | $54,397 |
| Metoprolol Succinate | 42 | $759 |
| Amiodarone Hcl | 11 | $500 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $270 |
| Rosuvastatin Calcium | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Boston
- Elad AnterBoston$3.9M
- Jagmeet SinghBoston$619K
- Andre DavilaBoston$379K
- Daniel KramerBoston$247K
- Gregory MichaudBoston$244K
- Laurence EpsteinBoston$172K
- Leon PtaszekBoston$168K
- Moussa MansourBoston$145K
- Andrew LockeBoston$145K
- Peter ZimetbaumBoston$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.